Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01678833 · ClinicalTrials.gov registry record

Understanding Drug Abuse Treatment Outcomes

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
7
Enrollment target

NCT01678833 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01678833 has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
7 participants
Enrollment target

Study Summary

Background: Although some treatments for substance abuse are considered effective for some people who are drug dependent, many others do not benefit as much over time. Researchers are working to find out what characteristics predict treatment response. They also want to determine how to design treatments that are more effective for a greater number of substance abusers. This pilot study involves providing drug addicts with cognitive behavioral therapy (CBT), a treatment considered to be one of the most effective in reducing substance-abuse, to identify ways in which the brain works that may predict and explain treatment effects. A comparison group will be included that receives only standard psychotherapy or talk therapy. This approach will enable researchers to determine what factors might be interfering with favorable treatment outcomes and how to refine or develop new treatments that work well for more people. Objectives: \- To identify individual characteristics which predict and explain the effects of CBT in people with opiate dependence. Eligibility: * Males between 18 and 60 years of age who are dependent on opioids (such as heroin). * Participants must be willing to take buprenorphine and receive substance abuse counseling. Design: * Participants will be screened with a physical exam and medical history. * Researchers will ask questions about participants ability to cope in certain situations, along with questions about drug use and lifestyle issues. These questions will be asked twice, before and after completing treatment. * Participants will be placed into one of two groups. One group will have CBT twice a week for 8 weeks. The other group will have standard counseling twice per week. Both groups will take buprenorphine as part of the drug abuse treatment. * Participants will have other tests during this study. They will have imaging studies to look at brain function. These studies will test thinking and decision making.

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2012-07-19
Est. Completion 2016-03-07

What the Registry Record Tells You About NCT01678833

The ClinicalTrials.gov registry entry for NCT01678833 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01678833 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01678833 about?

NCT01678833 is a clinical study titled "Understanding Drug Abuse Treatment Outcomes". Background: Although some treatments for substance abuse are considered effective for some people who are drug dependent, many others do not benefit as much over time. Researchers are working to find out what characteristics predict treatment response. They also want to determine how to design trea...

What is the current status of trial NCT01678833?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2012-07-19. Estimated completion is 2016-03-07.

Who is sponsoring clinical trial NCT01678833?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.